Cerebral Oxygenation to Guide Medical Interventions in Extremely Preterm Infants (SafeBoosC-p)
Safeguarding the Brains of Our Smallest Children - a Pilot Study
Sponsor: Cambridge University Hospitals NHS Foundation Trust
This PHASE1 trial investigates Near-infrared Spectroscopy and Oximetry and is currently completed. Cambridge University Hospitals NHS Foundation Trust leads this study, which shows 8 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jan 2019 — Jan 2021 [monthly]
Completed PHASE1
-
Nov 2018 — Jan 2019 [monthly]
Completed PHASE1
▶ Show 3 earlier versions
-
Aug 2018 — Nov 2018 [monthly]
Completed PHASE1
-
Jun 2018 — Aug 2018 [monthly]
Completed PHASE1
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE1
First recorded
Sep 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cambridge University Hospitals NHS Foundation Trust
- Copenhagen Trial Unit, Center for Clinical Intervention Research
- Elsass Foundation
- Gorm Greisen
- Hospices Civils de Lyon
- Hospital Universitario La Paz
- KU Leuven
- Medical University of Graz
- Universitair Medisch Centrum Utrecht
- University College Cork
- University of Milan
- University of Witten/Herdecke
- University of Zurich
- Uppsala University
For direct contact, visit the study record on ClinicalTrials.gov .